PDE4A and chronic obstructive pulmonary disease: PDE4 inhibitors can be used for long-term application as has been proven already by the clinical application of Roflumilast for the treatment of chronic obstructive lung disease with few unthreatening adverse effects such as diarrhea, nausea and weight loss [74].